Pi-Cardia
Latest round
- Series C
Last raised
- Jan 2016
Total raised
- $10M
Investors
- 5
About Pi-Cardia
Founded in 2009 and headquartered in Rehovot, Israel, Pi-Cardia Ltd. develops advanced medical devices aimed at structural heart disease. Erez Golan serves as both the CEO and a co-founder, alongside Rafi Benary. This investment reflects the company’s commitment to advancing its product offerings in the healthcare sector.Pi-Cardia specializes in innovative medical devices aimed at addressing structural heart disease, particularly through non-implant-based valve treatments. Their flagship products include the ShortCut™ device and the Leaflex™ Performer, designed for leaflet modification in bioprosthetic heart valves. The ShortCut™ device is FDA-cleared for splitting valve leaflets, addressing the critical risk of coronary obstruction in patients, while the Leaflex™ Performer remains an investigational device intended exclusively for clinical investigations. These products aim to simplify procedures by offering low-profile catheter solutions that require shorter hospitalization, making them particularly appealing to healthcare providers focused on efficiency and patient safety.Pi-Cardia generates revenue through direct sales of its medical devices to healthcare facilities, including hospitals and specialized cardiac centers. The business model operates on a B2B structure, where transactions occur as one-time purchases rather than subscriptions or recurring partnerships. Sales of the ShortCut™ device and Leaflex™ Performer are structured around unit pricing, with potential volume discounts offered to larger institutions. Given the specialized nature of these devices, the pricing aligns with the premium market for advanced medical technology, reflecting their innovative nature and the clinical benefits they provide. The company is focused on launching new products in the near future, particularly advancements in their catheter-based solutions. Additionally, Pi-Cardia aims to expand its market presence within Europe and the United States, targeting hospitals and cardiac care centers by the end of the next fiscal year.
Who invested in Pi-Cardia
5 investors across 3 rounds
See all investors in Pi-Cardia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pi-Cardia
Who invested in Pi-Cardia?
Pi-Cardia has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pi-Cardia raised?
Pi-Cardia has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Pi-Cardia last raise money?
Pi-Cardia's most recent round on record is a Series C, in Jan 2016.
What does Pi-Cardia do?
Founded in 2009 and headquartered in Rehovot, Israel, Pi-Cardia Ltd.
Where is Pi-Cardia headquartered?
Pi-Cardia is headquartered in Rehovot, Israel.
Which VCs invest in companies like Pi-Cardia?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Pi-Cardia's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Pi-Cardia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.